Metraipolis › archive › dc_11447e8bea30
Epitranscriptomic control of cancer immunity and therapy resistance — Europe PMC PMID:41280938
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41280938
- DOI
- 10.3389/fimmu.2025.1706557
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T17:45:50.076Z
- SHA-256 of the archived text
a05c461184371f9b1ae0478349ba71c600612760ef7af4a3d244650f0f1848a1- Stable URL of this page
https://metraipolis.com/documento/dc_11447e8bea30
How to cite
Epitranscriptomic control of cancer immunity and therapy resistance — Europe PMC PMID:41280938 — Europe PMC (en), https://europepmc.org/article/MED/41280938 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_11447e8bea30 (Metraipolis archive dc_11447e8bea30, sha256 a05c461184371f9b1ae0478349ba71c600612760ef7af4a3d244650f0f1848a1)
BibTeX
@misc{dc11447e8bea30,
title = {Epitranscriptomic control of cancer immunity and therapy resistance — Europe PMC PMID:41280938},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41280938},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_11447e8bea30; sha256 a05c461184371f9b1ae0478349ba71c600612760ef7af4a3d244650f0f1848a1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41280938. Agents can read the archived copy with the MCP tool read_document.